相关实验视频

Updated: Jan 11, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

从放射性铜到冷铜:机械建模和模拟以确定威尔逊病VTX-801临床反应标准和生物标志物

Andreas Lindauer¹, Bernard Benichou², Gloria González Aseguinolaza³

¹Calvagone SAS, Chazay d'Azergues, France.

CPT: pharmacometrics & systems pharmacology

|November 18, 2025

概括

铜代谢的新机制模型有助于对威尔逊病 (WD) 中的VTX-801基因疗法的生物标志物合格. 它确定了血放射性和相对可交换铜 (REC) 作为治疗反应的潜在生物标志物.

科学领域:

药理学药理学是指药理学的学科.
生物化学生物化学
系统生物学系统生物学

背景情况:

威尔逊病 (WD) 是一种由ATP7B基因突变引起的遗传疾病,导致铜积累.
VTX-801是一种基因疗法,旨在恢复ATP7B的功能.
准确的生物标志物对于评估治疗疗效和指导治疗决策至关重要.

研究的目的:

开发人类铜代谢的综合机械模型.
为了支持对威尔逊病的VTX-801基因疗法的生物标志物资格.
为评估治疗反应建立in silico标准.

主要方法:

综合生理铜动力学与WD病理生理学,区分黄胺结合和非黄胺结合的铜 (NCC).
嵌入的ATP7B依赖过程:胆道分泌和血清胺载荷.
使用文献数据和放射性铜研究验证模型;模拟冷铜动力学.

主要成果:

对于恢复ATP7B功能的衍生活性因子 (AFs),具有15%的最小和40%的最佳疗效目标.
模拟表明,48/2小时的血放射性比率有效地区分了VTX-801响应者.
确定了相对可交换铜 (REC) 作为一种潜在的非放射性生物标志物.

结论:

开发的模型提供了一个强大的定量框架,用于评估WD中的铜生物标志物.
该模型支持对VTX-801的疗效和反应进行in silico评估.
确定了血放射性比率和REC作为指导WD基因治疗的有前途的生物标志物.

关键词:

在ATP7B中,它是ATP7B.PBPKK PBPK 的意思是什么意思威尔逊病是威尔逊病的一种疾病.基因治疗的基因疗法放射性铜是使用的.

更多相关视频

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

相关概念视频

In Vitro Drug Dissolution: Compendial Testing Models I

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...

In Vitro Drug Dissolution: Compendial Testing Models II

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...